237.09+2.09 (+0.89%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 235.00 |
| Open | 235.00 |
| Bid | 65.65 x 900 |
| Ask | 255.10 x 800 |
| Day's Range | 231.87 - 240.22 |
| 52 Week Range | 63.16 - 279.46 |
| Volume | 63,193 |
| Avg. Volume | 122,791 |
| Market Cap | 2.788B |
| Beta (5Y Monthly) | 1.50 |
| PE Ratio (TTM) | 27.31 |
| EPS (TTM) | 8.68 |
| Earnings Date | May 03, 2021 - May 07, 2021 |
| Forward Dividend & Yield | 5.68 (2.40%) |
| Ex-Dividend Date | Mar 29, 2021 |
| 1y Target Est | 301.75 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
62% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Zacks
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
- Simply Wall St.
Is Medifast, Inc.'s(NYSE:MED) Recent Stock Performance Tethered To Its Strong Fundamentals?
Medifast's (NYSE:MED) stock is up by a considerable 15% over the past three months. Given the company's impressive...
- Zacks
Medifast (MED) Rallies More Than 25% in 6 Months: Here's Why
Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system, which is well placed given consumers' rising inclination toward health and wellness.
© 2021 Verizon Media. All rights reserved.
